Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor-α, basic fibroblast growth factor and copper as angiogenic markers in premenopausal breast cancer patients: a case-control study

References

• Rahman MA, Toi M. Anti-angiogenic therapy in breast cancer. Biomed Pharmacother 2003; 57: 463–70.
   Google Scholar
• Greenberg S, Rugo HS. Triple-negative breast cancer: role of antiangiogenic agents. Cancer J 2010; 16: 33–8.
   Google Scholar
• Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998; 82: 1007–15.
   Google Scholar
• Cooke JP, Losordo DW. Nitric oxide and angiogenesis. Circulation 2002; 105: 2133–41.
   Google Scholar
• Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002; 13: 135–41.
   Google Scholar
• Madhusudan S, Foster M, Muthuramalingam SR et al. A phase II study of etanercept (Enbrel), a tumor necrosis factor-alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res 2004; 10: 6528–34.
   Google Scholar
• Granato AM, Nanni O, Falcini F et al. Basic fibroblasts growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? Breast Cancer Res 2004; 6: R38–45.
   Google Scholar
• Tabibiazar R, Rockson SG. Angiogenesis and the ischaemic heart. Eur Heart J 2001; 22: 903–18.
   Google Scholar
• Matsuiki A, Ishiwata T, Watanabe M, Asano G. Expression of fibroblast growth factor (FGF)-10 in human colorectal adenocarcinoma cells. J Nippon Med Sch 2001; 68: 397–404.
   Google Scholar
• Pan Q, Kleer CG, Van Golen KL et al. Copper deficiency induced by tetra thiomolybdate suppresses tumor growth and metastasis. Cancer Res 2002; 62: 4854–9.
   Google Scholar
• Brem S, Wotoczek-Obadia MC. Regulation of angiogenesis by copper reduction and penicillamine: antagonism of cytokine and growth factor activity. Angiogenesis Cancer Res 1998; 2: 24–8.
   Google Scholar
• Raju KS, Alessandri G, Zinche M, Gullino PM. Ceruloplasmin, copper ions and angiogenesis. J Natl Cancer Inst 1982; 69: 1183–8.
   Google Scholar
• Parke A, Bhattacherjee P, Palmer RM, Lazarus NR. Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea. Am J Pathol 1988; 130: 173–8.
   Google Scholar
• Ziche M, Jones J, Gullino PM. Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 1982; 69: 475–82.
   Google Scholar
• Byrne GJ, Ghellal A, Iddon J et al. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst 2000; 92: 1329–36
   Google Scholar
• Davies G, Cunnick GH, Mansel ER, Mason MD, Jiang WG. Levels of expression of endothelial markers specific to tumorassociated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004; 21: 31–7.
   Google Scholar
• Tanaka F, Otake Y, Yanagihara K. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-Cd105 antibody. Clin Cancer Res 2001; 7: 3410–5.
   Google Scholar
• Tes NB, Shoker BS, Jarvis C. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. Br J Cancer 2002; 86: 905–11.
   Google Scholar
• Granato AM, Frassineti GL, Giovannini N et al. Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer? Tumour Biol 2006; 27: 302–8.
   Google Scholar
• Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anticancer strategy. Endocr Relat Cancer 2004; 11: 255–63.
   Google Scholar
• Guidi AJ, Berry DA, Broadwater G et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 2000; 92: 486–92.
   Google Scholar
• Nanus DM, Schmitz-Drager BJ, Motzer RJ et al. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 1993; 85: 1597–9.
   Google Scholar
• Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994; 85: 1045–9.
   Google Scholar
• Duffy MJ. Biochemical markers in breast cancer: which ones are clinically useful? Clin Biochem 2001; 34: 347–5.
   Google Scholar
• No authors listed. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996; 14: 2843–77.
   Google Scholar
• Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 2006; 52: 345–51.
   Google Scholar
• Haskell CM, Lowitz BB, Casciato AD. Breast cancer. In: Casciato AD, Lowitz BB eds. Manual of Clinical Oncology 2nd edn. Boston: Little and Brown, 1985: 150–65.
   Google Scholar
• Rintoul RF. Operations on the breast. In: Farquharson's Textbook of Operative Surgery 7th edn. Edinburgh: Churchill Livingstone, 1986: 270–81.
   Google Scholar
• Abeloff MD, Lichter AS, Niederhuber JE, Pierce LJ, Aziz DC. Breast. In: Abeloff MD, Armitage JO, Licher AS, Niederhuber JE eds. Clinical Oncology Edinburgh: Churchill Livingstone, 1995: 1617–714.
   Google Scholar
• Marzinzig M, Nussler AK, Stadler J et al. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate and S-nitrosothiols. Nitric Oxide 1997; 1: 177–89.
   Google Scholar
• Teppo AM, Maury C. Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987; 33: 2024–7.
   Google Scholar
• Chen Z, Fan Z, Yang J. Immunoradiometric assay of tumor marker CA15-3 and its clinical application (in Chinese). Zhonghua Zhong Liu Za Zhi 1998; 20: 125–8.
   Google Scholar
• Dirix LY, Vermeulen PB, Pawinski A et al. Elevated levels of the angiogenic cytokines, basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997; 76: 238–43.
   Google Scholar
• Tsalev DL. Atomic absorption spectrometry in occupational and environmental health practice. Progress in Analytical Methodology Vol III. Boca Raton: CRC Press, 1995.
   Google Scholar
• Rice A, Quinn CM. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol 2002; 55: 569–74.
   Google Scholar
• Weidner N, Semple P, Wele W, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.
   Google Scholar
• Weidner N, Folkman J, Pozza F et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875–87.
   Google Scholar
• Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993; 55: 371–4.
   Google Scholar
• Hork ER, Leek R, Klenk N et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120–4.
   Google Scholar
• Choi WW, Lewis MM, Lawson D et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005; 18: 143–52.
   Google Scholar
• Charpin C, Devictor B, Bergeret D et al. CD31 quantitative immunocytochemical assays in breast carcinomas. correlation with current prognostic factors. Am J Clin Pathol 1995; 103: 443–8.
   Google Scholar
• Ziche M, Morbidelli L, Masini E et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036–44.
   Google Scholar
• Konukoglu D, Turhan MS, Celik V, Turna H. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide and urokinase-type plasminogen activator in breast cancer patients. Indian J Med Res 2007; 125: 747–51.
   Google Scholar
• Coskun U, Gunel N, Sancak B et al. Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast 2003; 12: 104–10.
   Google Scholar
• Günel N, Coskun U, Sancak B et al. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage. Am J Clin Oncol 2003; 26: 416–21.
   Google Scholar
• Martin JH, Begum S, Alalami O, Harrison A, Scott KW. Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 2000; 21: 90–7.
   Google Scholar
• Murdoch WJ, Colgin DC, Ellis JA. Role of tumor necrosis factor-α in the ovulatory mechanism of ewes. J Anim Sci 1997; 75: 1601–5.
   Google Scholar
• Malik STA, Naylor S, East N, Oliff A, Balkwill FR. Cells secreting tumor necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 1990; 26: 1031–4.
   Google Scholar
• Orosz P, Krüger A, Hubbe M, Rüschoff J, Von Hoegen P, Männel DN. Promotion of experimental liver metastasis by tumor necrosis factor. Int J Cancer 1995; 60: 867–71.
   Google Scholar
• Moore RJ, Owens DM, Stamp G et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 1999; 5: 828–31.
   Google Scholar
• Seeger H, Wallwiener D, Mueck AO. Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells. Life Sci 2006; 78: 1464–8.
   Google Scholar
• Niedbala MJ. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl 1993; 42: 179–93.
   Google Scholar
• Sheen-Chen SM, Chen WJ, Eng HL, Chou FF. Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 1997; 43: 211–5.
   Google Scholar
• Basifico C, Moscateffi D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992; 59: 115–65.
   Google Scholar
• Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991; 88: 11007–11.
   Google Scholar
• Rowe JM, Kasper S, Shiu RPC, Friesen HG. Purification and characterization of a human mammary tumor-derived growth factor. Cancer Res 1986; 46: 1408–12.
   Google Scholar
• Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C. Serum evaluation of basic FGF in breast cancer patients. Anticancer Res 1995; 15: 2675–7.
   Google Scholar
• Dabek JT, Hyvönen-Dabek M, Härkönen M, Adlercreutz H. Evidence for increased non-ceruloplasmin copper in early-stage human breast cancer serum. Nutr Cancer 1992; 17: 195–201.
   Google Scholar
• Fisher GL, Spitler LE, McNeill KL, Rosenblatt LS. Serum copper and zinc levels in melanoma patients. Cancer 1981; 47: 1838–44.
   Google Scholar
• Li Y, Trush MA, Yagar JD. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis 1994; 15: 1421–7.
   Google Scholar
• Lowndes SA and Harris AL. The role of copper in tumor angiogenesis. J Mammary Gland Biol Neoplasia 2005; 10: 299–310.
   Google Scholar
• Gion M, Mione R, Leon AE, Dittadi R. Comparison of the diagnostic accuracy of CA27.29 and CA15-3 in primary breast cancer. Clin Chem 1999; 45: 630–7.
   Google Scholar
• Hagemann T, Wilson J, Kulbe H et al. Macrophages induce invasiveness of epithelial cancer cells via NF-ºB and JNK. J Immunol 2005; 175: 1197–205.
   Google Scholar
• Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605–12.
   Google Scholar
• Murohara T, Asahara T, Silver M et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998; 101: 2567–78.
   Google Scholar
• Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated regression. Cancer Cell 2004; 6: 297–305.
   Google Scholar
• Wu JT, Kral JG. The NF-ºB/IºB signaling system: a molecular target in breast cancer therapy. J Surg Res 2005; 123: 158–69.
   Google Scholar